
Update On Clinical Trials
FDA Qualifies First Surrogate Endpoint For Use In Osteoporosis Clinical Trials
December 22, 2025
Osteoporosis Canada is excited to share the US Food and Drug Administration (FDA) has qualified image-based biomarkers of bone mineral density (BMD) as a surrogate endpoint for bone fractures in clinical trials for osteoporosis drug candidates.
ASBMR (American Society for Bone and Mineral Research) and the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium, initiated a multi-sector partnership led by ASBMR thought leaders Dennis Black, PhD, from the University of California, San Francisco, Mary Bouxsein, PhD, from Harvard Medical School, and Richard Eastell, MD from the University of Sheffield School of Medicine and Population Health. The Study to Advance BMD as a Regulatory Endpoint, which has been called SABRE.
ASBMR provided financial support and institutional backing for the study, with the support of a number of public-private partnerships. It has continued under the leadership of multiple ASBMR Councils and presidents, including most recently Dr. Peter Ebeling, Dr. Mary Bouxsein, Dr. Laura Calvi and Dr. Jennifer Westendorf.
To learn more about this important news you can watch this video and hear from Dr. Black and Dr. Bouxsein about the ambitious effort and the tremendous impact this study will have on future clinical trials which will speed development of new drugs to treat osteoporosis.
This achievement will impact the lives of people affected with osteoporosis worldwide.
Congratulations to all involved!
OC MAKES THE NEWS – RECENT ITEMS
DENOZA® is now available in Canada
Latest News DENOZA® (denosumab injection), a biosimilar from Apotex, is now available in Canada September 25, 2026 PrDENOZA® is indicated for the treatment of postmenopausal osteoporosis, and to increase bone […]
Healthcare Professional Educational Events
Healthcare Professional Educational Events August 19, 2026 View the following information for two events for the healthcare professional: Canadian Symposia on Rare Bone Diseases 2026 ISCD Quality Bone Densitometry: for […]
Researchers Use Machine Learning To Better Predict Fractures Caused By Weak Bones
Latest News Researchers Use Machine Learning To Better Predict Fractures Caused By Weak Bones July 7, 2026 Fragility fractures are a major and growing health burden, with significant personal and […]

